Home/ Stocks/ LUCD

Lucid Diagnostics Inc. Common Stock

LUCD XNAS

$1.20 -0.03 (-2.40%) ▼ 15-min delayed

Open

$1.23

High

$1.25

Low

$1.18

Volume

359.9K

Market Cap

$163.87M

About Lucid Diagnostics Inc. Common Stock

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 70 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$1.21M	$-10,397,000	$-0.10
Q2 2025	$1.16M	$-4,439,000	$-0.08
Q1 2025	$828.0K	$-26,908,000	$-0.52
FY 2024	$4.35M	$-45,529,000	$-1.05

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for LUCD yet. Check out our latest market news or earnings calendar.

Get LUCD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lucid Diagnostics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.